GLABF (Gemina Laboratories) Scaled Net Operating Assets: -4.29 (As of Oct. 2025)


What is Gemina Laboratories Scaled Net Operating Assets?

Gemina Laboratories GLABF -27.59% Scaled Net Operating Assets is -4.29 as of Oct. 2025. The stock has 2 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Gemina Laboratories's operating assets for the quarter that ended in Oct. 2025 was $0.80 Mil. Gemina Laboratories's operating liabilities for the quarter that ended in Oct. 2025 was $4.30 Mil. Gemina Laboratories's Total Assets for the quarter that ended in Jul. 2025 was $0.82 Mil. Therefore, Gemina Laboratories's scaled net operating assets (SNOA) for the quarter that ended in Oct. 2025 was -4.29.

Gemina Laboratories Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Scaled Net Operating Assets Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Scaled Net Operating Assets
-0.25 -0.07 0.06 -0.59 -2.03

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.36 -1.98 -2.98 -3.93 -4.29

GLABF vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Gemina Laboratories's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Scaled Net Operating Assets falls into.


Gemina Laboratories Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Gemina Laboratories's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jan. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jan. 2025 )
=(Operating Assets (A: Jan. 2025 )-Operating Liabilities (A: Jan. 2025 ))/Total Assets (A: Jan. 2024 )
=(0.998-3.197)/1.085
=-2.03

where

Operating Assets(A: Jan. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.999 - 0.001
=0.998

Operating Liabilities(A: Jan. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.082 - 0.122 - 0.763
=3.197

Gemina Laboratories's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Oct. 2025 )
=(Operating Assets (Q: Oct. 2025 )-Operating Liabilities (Q: Oct. 2025 ))/Total Assets (Q: Jul. 2025 )
=(0.795-4.298)/0.817
=-4.29

where

Operating Assets(Q: Oct. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.794 - -0.001
=0.795

Operating Liabilities(Q: Oct. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.47 - 0 - 0.172
=4.298

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -4.29 mean?
Gemina Laboratories (GLABF) has a Scaled Net Operating Assets of -4.29 as of Oct. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Scaled Net Operating Assets too high?
Gemina Laboratories' current Scaled Net Operating Assets is -4.29.
How does Gemina Laboratories' Scaled Net Operating Assets compare to VRTX and REGN?
Gemina Laboratories' Scaled Net Operating Assets of -4.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Scaled Net Operating Assets is -4.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Scaled Net Operating Assets of -4.29. The current Scaled Net Operating Assets is -4.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Scaled Net Operating Assets is -4.29 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.